$147 Million is the total value of Nan Fung Group Holdings Ltd's 44 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 14.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KRTX | KARUNA THERAPEUTICS INC | $40,993,968 | -7.6% | 225,688 | 0.0% | 27.90% | -8.7% | |
| ILMN | ILLUMINA INC | $27,719,030 | +15.0% | 119,196 | 0.0% | 18.86% | +13.6% | |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | $12,036,912 | -40.7% | 368,665 | 0.0% | 8.19% | -41.5% | |
| SGEN | SEAGEN INC | $9,535,527 | +57.6% | 47,096 | 0.0% | 6.49% | +55.6% | |
| New | OCULIS HOLDING AGordinary shares | $4,837,673 | – | 651,100 | +100.0% | 3.29% | – | |
| Buy | EXSCIENTIA PLCads | $4,557,428 | +0.2% | 859,892 | +0.8% | 3.10% | -1.0% | |
| SOMALOGIC INC | $4,326,223 | +1.6% | 1,696,558 | 0.0% | 2.94% | +0.3% | ||
| XENE | XENON PHARMACEUTICALS INC | $4,093,660 | -9.2% | 114,380 | 0.0% | 2.79% | -10.3% | |
| REPL | REPLIMUNE GROUP INC | $3,343,727 | -35.1% | 189,339 | 0.0% | 2.28% | -35.9% | |
| MRUS | Buy | MERUS N V | $2,778,400 | +91.6% | 151,000 | +61.1% | 1.89% | +89.3% |
| ISEE | IVERIC BIO INC | $2,724,571 | +13.6% | 111,984 | 0.0% | 1.85% | +12.2% | |
| KDNY | CHINOOK THERAPEUTICS INC | $2,637,943 | -11.6% | 113,950 | 0.0% | 1.80% | -12.7% | |
| BGNE | BEIGENE LTDsponsored adr | $2,591,102 | -2.0% | 12,022 | 0.0% | 1.76% | -3.2% | |
| RANI THERAPEUTICS HLDGS INC | $2,546,893 | -12.5% | 493,584 | 0.0% | 1.73% | -13.6% | ||
| INCY | INCYTE CORP | $2,485,438 | -10.0% | 34,391 | 0.0% | 1.69% | -11.1% | |
| BMEA | BIOMEA FUSION INC | $1,860,600 | +267.9% | 60,000 | 0.0% | 1.27% | +263.8% | |
| BOLT | BOLT BIOTHERAPEUTICS INC | $1,622,063 | +6.9% | 1,166,952 | 0.0% | 1.10% | +5.6% | |
| PACB | PACIFIC BIOSCIENCES CALIF IN | $1,582,465 | +41.6% | 136,655 | 0.0% | 1.08% | +39.9% | |
| GRTX | GALERA THERAPEUTICS INC | $1,569,851 | +71.8% | 613,223 | 0.0% | 1.07% | +69.5% | |
| Buy | GITLAB INC | $1,267,084 | +303.5% | 36,952 | +434.8% | 0.86% | +299.1% | |
| EXEL | EXELIXIS INC | $1,246,122 | +21.0% | 64,200 | 0.0% | 0.85% | +19.4% | |
| MELI | New | MERCADOLIBRE INC | $1,191,526 | – | 904 | +100.0% | 0.81% | – |
| ENTRADA THERAPEUTICS INC | $1,066,939 | +7.2% | 73,582 | 0.0% | 0.73% | +6.0% | ||
| AVTE | Sell | AEROVATE THERAPEUTICS INC | $966,869 | -34.8% | 47,936 | -5.3% | 0.66% | -35.6% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $701,587 | +10.9% | 7,215 | +18.0% | 0.48% | +9.4% |
| New | EARGO INC | $692,191 | – | 147,904 | +100.0% | 0.47% | – | |
| FGEN | FIBROGEN INC | $636,418 | +16.5% | 34,106 | 0.0% | 0.43% | +15.2% | |
| DBVT | DBV TECHNOLOGIES S Asponsored adr | $626,906 | +10.5% | 370,950 | 0.0% | 0.43% | +9.2% | |
| KALV | KALVISTA PHARMACEUTICALS INC | $618,739 | +16.3% | 78,720 | 0.0% | 0.42% | +14.7% | |
| RYTM | RHYTHM PHARMACEUTICALS INC | $580,157 | -38.7% | 32,520 | 0.0% | 0.40% | -39.4% | |
| TVTX | TRAVERE THERAPEUTICS INC | $575,879 | +6.9% | 25,606 | 0.0% | 0.39% | +5.7% | |
| ACAD | ACADIA PHARMACEUTICALS INC | $564,299 | +18.2% | 29,984 | 0.0% | 0.38% | +16.7% | |
| ARGX | Buy | ARGENX SEsponsored adr | $532,789 | +26.7% | 1,430 | +28.8% | 0.36% | +25.2% |
| ASND | ASCENDIS PHARMA A/Ssponsored adr | $446,893 | -12.2% | 4,168 | 0.0% | 0.30% | -13.4% | |
| MDGL | MADRIGAL PHARMACEUTICALS INC | $286,351 | -16.5% | 1,182 | 0.0% | 0.20% | -17.4% | |
| AFMD | AFFIMED N V | $277,715 | -39.9% | 372,472 | 0.0% | 0.19% | -40.6% | |
| ALXO | ALX ONCOLOGY HLDGS INC | $189,614 | -59.9% | 41,950 | 0.0% | 0.13% | -60.4% | |
| BCRX | New | BIOCRYST PHARMACEUTICALS INC | $148,844 | – | 17,847 | +100.0% | 0.10% | – |
| STSA | SATSUMA PHARMACEUTICALS INC | $124,263 | -22.4% | 177,900 | 0.0% | 0.08% | -22.7% | |
| KOD | KODIAK SCIENCES INC | $121,656 | -13.4% | 19,622 | 0.0% | 0.08% | -14.4% | |
| NRIX | NURIX THERAPEUTICS INC | $102,120 | -19.1% | 11,500 | 0.0% | 0.07% | -20.7% | |
| ABCL | ABCELLERA BIOLOGICS INC | $94,408 | -25.6% | 12,521 | 0.0% | 0.06% | -26.4% | |
| CERS | CERUS CORP | $42,091 | -18.6% | 14,172 | 0.0% | 0.03% | -19.4% | |
| NVTA | INVITAE CORP | $15,305 | -27.4% | 11,337 | 0.0% | 0.01% | -33.3% | |
| SYBX | Exit | SYNLOGIC INC | $0 | – | -68,634 | -100.0% | -0.04% | – |
| EAR | Exit | EARGO INC | $0 | – | -2,958,099 | -100.0% | -1.17% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| KARUNA THERAPEUTICS INC | 10 | Q3 2023 | 34.7% |
| HARMONY BIOSCIENCES HLDGS IN | 10 | Q3 2023 | 21.3% |
| XENON PHARMACEUTICALS INC | 10 | Q3 2023 | 3.1% |
| BOLT BIOTHERAPEUTICS INC | 10 | Q3 2023 | 5.6% |
| GALERA THERAPEUTICS INC | 10 | Q3 2023 | 1.9% |
| KALVISTA PHARMACEUTICALS INC | 10 | Q3 2023 | 1.8% |
| EXELIXIS INC | 10 | Q3 2023 | 1.1% |
| DBV TECHNOLOGIES S A | 10 | Q3 2023 | 0.6% |
| ALX ONCOLOGY HLDGS INC | 10 | Q3 2023 | 1.0% |
| ILLUMINA INC | 9 | Q3 2023 | 21.5% |
View Nan Fung Group Holdings Ltd's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Eargo, Inc. | December 16, 2022 | 2,958,099 | 0.7% |
| Stealth BioTherapeutics Corp | January 09, 2020 | 20,240,817 | 4.8% |
| New Frontier Health Corp | January 02, 2020 | 9,650,000 | 7.3% |
View Nan Fung Group Holdings Ltd's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13D/A | 2022-12-16 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
View Nan Fung Group Holdings Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.